Editorial: in-and-out blood vessels: new insights into T cell reverse transmigration.
Raffaghello
Lizzia
L
Pistoia
Vito
V
D019380:Anti-HIV Agents / Q000276:immunology / Q000494:pharmacology; D001596:Benzylamines; D002478:Cells, Cultured; D018946:Chemokine CCL5 / Q000276:immunology* / Q000494:pharmacology; D054377:Chemokine CXCL12 / Q000276:immunology* / Q000494:pharmacology; D002633:Chemotaxis / Q000187:drug effects / Q000276:immunology*; D018920:Coculture Techniques; D000080027:Cyclams; D004305:Dose-Response Relationship, Drug; D004730:Endothelium, Vascular / Q000166:cytology / Q000276:immunology*; D006571:Heterocyclic Compounds / Q000276:immunology / Q000494:pharmacology; D006801:Humans; D013312:Stress, Physiological / Q000276:immunology*; D013601:T-Lymphocytes / Q000166:cytology / Q000276:immunology*
D019380:Anti-HIV Agents; D001596:Benzylamines; C483024:CCL5 protein, human; C515255:CXCL12 protein, human; D018946:Chemokine CCL5; D054377:Chemokine CXCL12; D000080027:Cyclams; D006571:Heterocyclic Compounds; C088327:plerixafor